Published in Clin Infect Dis on January 01, 2007
Clinical practice: Herpes zoster. N Engl J Med (2013) 5.16
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve. J Infect Dis (2014) 2.46
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Herpes zoster. BMJ (2007) 1.91
Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis (2014) 1.91
Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open (2014) 1.81
Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc (2011) 1.75
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med (2010) 1.15
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11
Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol (2014) 1.11
Herpes zoster and postherpetic neuralgia: past, present and future. Pain Res Manag (2009) 1.10
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis (2011) 1.06
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study. Health Qual Life Outcomes (2014) 1.04
Characterization of the host immune response in human Ganglia after herpes zoster. J Virol (2010) 1.00
Viral infections of the central nervous system: a case-based review. Clin Med Res (2009) 0.97
An unexpected case of Ramsay Hunt syndrome: case report and literature review. BMC Res Notes (2013) 0.96
The search for new therapies for human cytomegalovirus infections. Virus Res (2010) 0.95
Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol (2010) 0.93
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract (2010) 0.93
Management and prevention of herpes zoster: A Canadian perspective. Can J Infect Dis Med Microbiol (2010) 0.92
Orbital apex syndrome: an unusual complication of herpes zoster ophthalmicus. BMC Infect Dis (2015) 0.92
Focal encephalitis following varicella-zoster virus reactivation without rash in a healthy immunized young adult. J Infect Dis (2014) 0.91
Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report. J Headache Pain (2012) 0.90
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med (2007) 0.87
Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother (2013) 0.87
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
The evidence base for the evaluation and management of dizziness. J Eval Clin Pract (2010) 0.86
VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol (2010) 0.85
Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis (2014) 0.85
Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis (2014) 0.83
Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy? Br J Gen Pract (2012) 0.83
Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Hum Vaccin Immunother (2015) 0.83
Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France. BMC Infect Dis (2015) 0.83
Neuropathic pain. Nat Rev Dis Prim (2017) 0.82
Post-herpetic neuralgia. Int J Gen Med (2012) 0.82
High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.82
Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan. PLoS One (2015) 0.82
Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses. Epidemiol Health (2014) 0.81
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis (2017) 0.81
Vaccines for the elderly need to be introduced into the immunization program in India. Hum Vaccin Immunother (2014) 0.81
Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma. BMJ Case Rep (2014) 0.80
Herpes zoster: unusual cause of acute urinary retention and constipation. Can Fam Physician (2013) 0.80
Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis (2014) 0.80
Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients. Indian J Dermatol (2012) 0.80
Herpes zoster correlates with pyogenic liver abscesses in Taiwan. Biomedicine (Taipei) (2016) 0.80
One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC Infect Dis (2014) 0.79
Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects. Clin Vaccine Immunol (2012) 0.78
Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate. Antimicrob Agents Chemother (2015) 0.78
Chronic pain patients' treatment preferences: a discrete-choice experiment. Eur J Health Econ (2014) 0.78
Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study. BMC Complement Altern Med (2011) 0.77
ARIZONA study: is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients? BMC Infect Dis (2014) 0.77
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med (2009) 0.77
Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia. J Pain Res (2016) 0.77
Vaccination to prevent zoster in the elderly. Epidemiol Infect (2007) 0.77
Postherpetic neuralgia. BMJ Clin Evid (2010) 0.76
Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States. Open Forum Infect Dis (2016) 0.76
Pathogenesis of varicelloviruses in primates. J Pathol (2015) 0.76
The societal impact of herpes zoster and postherpetic neuralgia on patients, life partners, and children of patients in Germany. ScientificWorldJournal (2014) 0.76
The epidemiology of herpes zoster and its complications in Medicare cancer patients. BMC Infect Dis (2015) 0.76
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study. BMC Infect Dis (2014) 0.76
Optimizing the Use of Chief Complaint & Diagnosis for Operational Decision Making: An EMR Case Study of the 2010 Haiti Earthquake. PLoS Curr (2014) 0.75
Ramsay Hunt syndrome in a patient with human immunodeficiency virus infection. Indian J Sex Transm Dis (2017) 0.75
Risk Factor and Prevention of Postherpetic Neuralgia. Korean J Pain (2015) 0.75
A Case of Ramsay Hunt Syndrome with Atypical Presentation. Turk J Emerg Med (2016) 0.75
Shingles with secondary asymptomatic CNS involvement! BMJ Case Rep (2012) 0.75
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study. Clinicoecon Outcomes Res (2016) 0.75
A Prospective Study of Herpes Zoster in Children. Indian J Dermatol (2016) 0.75
Atypical Presentation of Herpes Zoster Duplex Bilateralis in a Renal Transplanted Patient. Healthcare (Basel) (2013) 0.75
Herpes zoster ophthalmicus complicated by encephalitis. CMAJ (2015) 0.75
Herpes zoster during pregnancy. Can Fam Physician (2011) 0.75
Blindness resulting from orbital complications of ophthalmic zoster. Postepy Dermatol Alergol (2015) 0.75
Breast implant extrusion related to Herpesviridae. Int J Surg Case Rep (2015) 0.75
Herpes zoster segmental paresis in an immunocompromised breast cancer woman. Adv Biomed Res (2015) 0.75
Herpes zoster ophthalmicus progressing to encephalitis: beware pain preceding the rash. BMJ Case Rep (2013) 0.75
Herpes Zoster Induced Alveolar Bone Necrosis in Immunocompromised Patients; Two Case Reports. Iran J Otorhinolaryngol (2016) 0.75
A study on efficacy of Pregabalin in acute Herpetic Neuralgia. Ann Neurosci (2011) 0.75
Acute shingles after resection of thoracic schwannoma. Tex Heart Inst J (2012) 0.75
Full recovery of a 13-year-old boy with pediatric Ramsay Hunt syndrome using a shorter course of aciclovir and steroid at lower doses: a case report. J Med Case Rep (2011) 0.75
Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study. J Dent (Shiraz) (2014) 0.75
Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013. Neurol Res Int (2015) 0.75
Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.75
Herpes Zoster with Post Herpetic Neuralgia Involving the Right Maxillary Branch of Trigeminal Nerve: A Case Report and Review of Literature. J Clin Diagn Res (2017) 0.75
Orbital apex syndrome and meningoencephalitis: a rare complication of herpes zoster. Int J Clin Exp Med (2015) 0.75
A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review. BMC Pharmacol Toxicol (2017) 0.75
The Uncommon Localization of Herpes Zoster. Med Arch (2016) 0.75
Herpes Zoster and Recurrent Herpes Zoster. Open Forum Infect Dis (2017) 0.75
A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China. BMC Infect Dis (2017) 0.75
Ramsay Hunt syndrome after cervical zoster in an immunocompetent patient. Neurol Sci (2014) 0.75
Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien Klin Wochenschr (2014) 0.75
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet (2007) 5.20
Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med (2004) 5.04
Clinical practice. Herpes zoster. N Engl J Med (2002) 4.72
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 4.23
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis (2007) 4.23
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med (2007) 3.92
Viral encephalitis: familiar infections and emerging pathogens. Lancet (2002) 3.80
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med (2003) 3.67
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA (2004) 3.47
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr (2003) 3.38
Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis (2010) 3.07
Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain (2010) 2.90
Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology (2013) 2.79
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77
Interventional management of neuropathic pain: NeuPSIG recommendations. Pain (2013) 2.75
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med (2010) 2.73
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep (2006) 2.62
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol (2008) 2.60
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Informed Consent. N Engl J Med (2017) 2.56
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55
Effectiveness over time of varicella vaccine. JAMA (2004) 2.52
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin (2009) 2.51
Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med (2008) 2.44
Varicella vaccine--are two doses better than one? N Engl J Med (2002) 2.40
An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain (2007) 2.37
Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis (2008) 2.37
Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2008) 2.33
Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry (2009) 2.31
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol (2007) 2.26
Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med (2012) 2.25
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Treatment of postmastectomy pain with ambulatory continuous paravertebral nerve blocks: a randomized, triple-masked, placebo-controlled study. Reg Anesth Pain Med (2014) 2.20
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther (2008) 2.17
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain (2004) 2.15
Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes. Ophthalmology (2012) 2.13
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13
The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother (2012) 2.11
Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain (2015) 2.11
Cervical transforaminal epidural steroid injections: more dangerous than we think? Spine (Phila Pa 1976) (2007) 2.10
Classification of patients with pain based on neuropathic pain symptoms: comparison of an artificial neural network against an established scoring system. Eur J Pain (2006) 2.09
Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract (2002) 2.08
The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain (2007) 2.08
Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol (2005) 2.08
Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med (2014) 2.07
Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain (2002) 2.03
Central neuropathic itch from spinal-cord cavernous hemangioma: a human case, a possible animal model, and hypotheses about pathogenesis. Pain (2005) 2.02
Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: a cross-sectional study. Int J Nurs Stud (2011) 2.02
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine (2007) 2.01
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology (2005) 2.00
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis (2004) 2.00
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis (2012) 1.98
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med (2005) 1.96
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev (2003) 1.95
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain (2012) 1.94
The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976) (2012) 1.92
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol (2009) 1.92